← 產業報告目錄
France Advanced Wound Care Market Research Report by Material Type [Dressings (Alginate Dressings, Composite Dressings, Contact Layer Dressings, Hydrocolloid Dressings, Others), Powder (Styptic Powder, Hemostatic Powder), Gels, Devices], by Product Type (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Surgical & Traumatic Wounds, Burns, Others), by Application (Hospitals & Clinics, Ambulatory Surgical Centers, Others) Forecast till 2035
授權報價
| Single User Price | $2,950 USD |
| Multi User Licence (up to 10 users) | $3,950 USD |
| Enterprisewide Price (Global Site License) | $5,250 USD |
報告摘要
France Advanced Wound Care Market Research Report by Material Type [Dressings (Alginate Dressings, Composite Dressings, Contact Layer Dressings, Hydrocolloid Dressings, Others), Powder (Styptic Powder, Hemostatic Powder), Gels, Devices], by Product Type (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Surgical & Traumatic Wounds, Burns, Others), by Application (Hospitals & Clinics, Ambulatory Surgical Centers, Others) Forecast till 2035
Market Overview
The France advanced wound care market is projected to grow from USD 1,046.39 million in 2024 to USD 1,894.88 million by 2035, registering a CAGR of 5.68% between 2025 and 2035. Advanced wound care refers to specialized medical treatments and technologies designed to promote faster, safer, and more effective healing of complex or chronic wounds. It goes beyond traditional dressings by incorporating therapies such as negative pressure, bioengineered tissue, and advanced dressings that support tissue regeneration and reduce infection risks.
The rising prevalence of chronic wounds, particularly diabetic foot ulcers, pressure ulcers, and venous leg ulcers, is a major driver of the France advanced wound care market. The demand for novel treatments has increased due to the rising rates of diabetes, obesity, and an elderly population. Besides that, the market is witnessing a wide range of opportunities for special solutions that are supported by the concerted effort of the multidisciplinary foot care units and government healthcare initiatives, as well as the progression in wound dressing, healing agents, and closure devices.
Key Company Development
Integra LifeSciences Holdings Corporation has been taking major steps to broaden its advanced wound care offering. In August 2020, it created the 360° Advanced Wound Care website, a customer resource that is user-friendly and comprises product information, training content, and educational materials. A new website highlighted a solid product lineup, including MediHoney, Omnigraft, PriMatrix, AmnioExcel, TCC-EZ, Bioguard, and Algicell Ag. In July 2019, Integra made a strategic alliance with Tissue Analytics, a company that uses AI technology to assess wounds digitally. The fusion of digital monitoring with its wound healing expertise will improve the clinical trial process and provide support for innovation in advanced wound care solutions.
Major Players
Key players in the France advanced wound care market are Johnson & Johnson, Inc., Smith + Nephew, Integra Lifesciences Holdings Corporation, 3M, ConvaTech Group Plc, Paul Hartmann AG, Coloplast, Mölnlycke AB, B.Braun SE, and Medline Industries, LP.
Report Attribute Details
Market Size 2024 USD 1,046.39 Million
Market Size 2035 USD 1,894.88Million
CAGR (2025-2035) 5.68%
Base Year 2024
Market Forecast Period 2025-2035
Historical Data 2019-2024
Market Segmentations
By Material Type: Dressings - 4.38%, Powder – 5.68%.
By Product Type: Diabetic Foot Ulcers – 6.45%, Pressure Ulcers – 5.74%.
By Application: Hospitals & Clinics – 5.49%, Ambulatory Surgical Centers – 7.06%.
目錄 Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ... 13
2 MARKET INTRODUCTION ......... 15
2.1 DEFINITION ......... 15
2.2 SCOPE OF THE STUDY ....... 15
2.3 RESEARCH OBJECTIVE ..... 15
2.4 MARKET STRUCTURE ....... 16
3 RESEARCH METHODOLOGY ... 17
3.1 OVERVIEW ........... 17
3.2 DATA FLOW ......... 19
3.2.1 DATA MINING PROCESS ... 19
3.3 PURCHASED DATABASE: ........... 20
3.4 SECONDARY SOURCES: ..... 21
3.4.1 SECONDARY RESEARCH DATA FLOW: .......... 22
3.5 PRIMARY RESEARCH: ........ 23
3.5.1 PRIMARY RESEARCH DATA FLOW: ..... 24
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED .......... 25
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: .......... 26
3.6.1 REVENUE ANALYSIS APPROACH ......... 26
3.7 DATA FORECASTING.......... 27
3.7.1 DATA FORECASTING TYPE ......... 27
3.8 DATA MODELING ........ 28
3.8.1 MICROECONOMIC FACTOR ANALYSIS: ......... 28
3.8.2 DATA MODELING: .... 29
3.9 TEAMS AND ANALYST CONTRIBUTION ........ 31
4 MARKET DYNAMICS ........ 33
4.1 INTRODUCTION ........... 33
4.2 DRIVERS ....... 33
4.2.1 RISING PREVALENCE OF CHRONIC WOUNDS ......... 34
4.2.2 GOVERNMENT INITIATIVES DRIVING THE ADVANCED WOUND CARE MARKET ..... 34
4.3 RESTRAINTS ....... 35
4.3.1 HIGH COST OF ADVANCED WOUND CARE PRODUCTS ..... 35
4.3.2 LIMITED AWARENESS AND TRAINING AMONG HEALTHCARE PROVIDERS ... 36
4.4 OPPORTUNITY .... 36
4.4.1 RESEARCH AND DEVELOPMENT INITIATIVES ........ 36
4.4.2 ADVANCEMENTS IN WOUND DRESSING MATERIALS ....... 37
5 MARKET FACTOR ANALYSIS ... 38
5.1 PORTER'S FIVE FORCES MODEL ...... 38
5.1.1 THREAT OF NEW ENTRANTS ...... 38
5.1.2 BARGAINING POWER OF SUPPLIERS ... 38
5.1.3 THREAT OF SUBSTITUTES ......... 39
5.1.4 BARGAINING POWER OF BUYERS ........ 39
5.1.5 INTENSITY OF RIVALRY .... 39
5.2 IMPACT OF COVID-19 ON THE FRANCE ADVANCED WOUND CARE MARKET ......... 39
5.3 REGULATORY LANDSCAPE IN EUROPE AND FRANCE ......... 40
5.4 REIMBURSEMENT STRATEGY FOR FRANCE ........ 41
5.5 MARKET TRENDS FOR FRANCE ...... 41
5.6 IMPACT OF MDR ON WOUND CARE MARKET IN FRANCE .......... 42
6 FRANCE ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE ... 45
6.1 OVERVIEW ........... 45
7 FRANCE ADVANCED WOUND CARE MARKET, BY APPLICATION ....... 50
7.1 OVERVIEW ........... 50
8 FRANCE ADVANCED WOUND CARE MARKET, BY END USER ... 54
8.1 OVERVIEW ........... 54
9 EUROPE ADVANCED WOUND CARE MARKET, .......... 57
9.1 OVERVIEW ........... 57
10 COMPETITIVE LANDSCAPE ..... 62
10.1 INTRODUCTION ........... 62
10.2 MARKET SHARE ANALYSIS, 2024 ........... 62
10.3 COMPETITOR DASHBOARD....... 63
10.4 PUBLIC PLAYERS STOCK SUMMARY ..... 64
10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL ...... 64
10.1 KEY DEVELOPMENTS & GROWTH STRATEGIES ........... 65
10.1.1 PRODUCT LAUNCH ........... 65
10.1.2 PRODUCT APPROVAL ....... 65
10.1.3 WEBSITE LAUNCH ... 65
10.1.4 PARTNERSHIP ......... 66
10.1.5 UPGRADATION ........ 66
10.1.6 ACQUISITION .......... 66
10.1.7 COLLABORATION .... 67
11 COMPANY PROFILES ...... 68
11.1 INTEGRA LIFESCIENCES HOLDINGS CORPORATION .... 68
11.1.1 COMPANY OVERVIEW ....... 68
11.1.2 FINANCIAL OVERVIEW ...... 69
11.1.3 PRODUCTS OFFERED ........ 70
11.1.4 KEY DEVELOPMENTS ........ 70
11.1.5 SWOT ANALYSIS ..... 71
11.1.6 KEY STRATEGIES ..... 71
11.2 3M ......... 72
11.2.1 COMPANY OVERVIEW ....... 72
11.2.2 FINANCIAL OVERVIEW ...... 73
11.2.3 PRODUCTS OFFERED ........ 74
11.2.4 KEY DEVELOPMENTS ........ 74
11.2.5 SWOT ANALYSIS ..... 75
11.2.6 KEY STRATEGIES ..... 75
11.3 COLOPLAST.......... 76
11.3.1 COMPANY OVERVIEW ....... 76
11.3.2 FINANCIAL OVERVIEW ...... 77
11.3.3 PRODUCTS OFFERED ........ 77
11.3.4 KEY DEVELOPMENTS ........ 78
11.3.5 KEY DEVELOPMENTS ........ 78
11.3.6 KEY STRATEGIES ..... 79
11.4 PAUL HARTMANN AG ....... 80
11.4.1 COMPANY OVERVIEW ....... 80
11.4.2 FINANCIAL OVERVIEW ...... 81
11.4.3 PRODUCTS OFFERED ........ 81
11.4.4 KEY DEVELOPMENTS ........ 82
11.4.5 KEY STRATEGIES ..... 82
11.5 MÖLNLYCKE AB.......... 83
11.5.1 COMPANY OVERVIEW ....... 83
11.5.2 FINANCIAL OVERVIEW ...... 84
11.5.3 PRODUCTS OFFERED ........ 84
11.5.4 KEY DEVELOPMENTS ........ 85
11.5.5 KEY STRATEGIES ..... 85
11.6 B. BRAUN SE ........ 87
11.6.1 COMPANY OVERVIEW ....... 87
11.6.2 FINANCIAL OVERVIEW ...... 88
11.6.3 PRODUCTS OFFERED ........ 89
11.6.4 KEY DEVELOPMENTS ........ 89
11.6.5 SWOT ANALYSIS ..... 90
KEY STRATEGIES ........ 90
11.7 SMITH+NEPHEW ........ 91
11.7.1 COMPANY OVERVIEW ....... 91
11.7.2 FINANCIAL OVERVIEW ...... 92
11.7.3 PRODUCTS OFFERED ........ 92
11.7.4 KEY DEVELOPMENTS ........ 93
11.7.5 SWOT ANALYSIS ..... 93
11.7.6 KEY STRATEGIES ..... 94
11.8 CONVATEC GROUP PLC ..... 95
11.8.1 COMPANY OVERVIEW ....... 95
11.8.2 FINANCIAL OVERVIEW ...... 96
11.8.3 PRODUCT OFFERED .......... 96
11.8.4 KEY DEVELOPMENTS ........ 97
11.8.5 KEY STRATEGIES ..... 98
11.9 JOHNSON & JOHNSON INC. ....... 99
11.9.1 COMPANY OVERVIEW ....... 99
11.9.2 FINANCIAL OVERVIEW ...... 100
11.9.3 PRODUCTS OFFERED ........ 101
11.9.4 KEY DEVELOPMENTS ........ 101
11.9.5 KEY STRATEGIES ..... 101
11.10 MEDLINE INDUSTRIES, LP ........ 102
11.10.1 COMPANY OVERVIEW ....... 102
11.10.2 FINANCIAL OVERVIEW ...... 103
11.10.3 PRODUCTS OFFERED ........ 103
11.10.4 KEY DEVELOPMENTS ........ 103
11.10.5 KEY STRATEGIES ..... 104
12 DATA CITATIONS .... 105
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 29
TABLE 2 FRANCE ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 47
TABLE 3 FRANCE ADVANCED WOUND CARE MARKET, FOR DRESSINGS, BY BTYPE, 2019–2035 (USD MILLION) 48
TABLE 4 FRANCE ADVANCED WOUND CARE MARKET, FOR POWDER, BY BTYPE, 2019–2035 (USD MILLION) 48
TABLE 5 FRANCE ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 53
TABLE 6 FRANCE ADVANCED WOUND CARE MARKET, BY END USER, 2019–2035 (USD MILLION) 56
TABLE 7 EUROPE ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 58
TABLE 8 EUROPE ADVANCED WOUND CARE MARKET, FOR DRESSINGS, BY TYPE, 2019–2035 (USD MILLION) 59
TABLE 9 EUROPE ADVANCED WOUND CARE MARKET, FOR POWDER, BY TYPE, 2019–2035 (USD MILLION) 59
TABLE 10 EUROPE ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 60
TABLE 11 EUROPE ADVANCED WOUND CARE MARKET, BY END USER, 2019–2035 (USD MILLION) 60
TABLE 12 PRODUCT LAUNCH 65
TABLE 13 PRODUCT APPROVAL 65
TABLE 14 WEBSITE LAUNCH 65
TABLE 15 PARTNERSHIP 66
TABLE 16 UPGRADATION 66
TABLE 17 ACQUISITION 66
TABLE 18 COLLABORATION 67
TABLE 19 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT OFFERED 70
TABLE 20 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY DEVELOPMENTS 70
TABLE 21 3M: PRODUCTS OFFERED 74
TABLE 22 3M: KEY DEVELOPMENTS 74
TABLE 23 COLOPLAST: PRODUCTS OFFERED 77
TABLE 24 PAUL HARTMANN AG: PRODUCTS OFFERED 81
TABLE 25 PAUL HARTMANN AG: KEY DEVELOPMENTS 82
TABLE 26 MÖLNLYCKE AB: PRODUCTS OFFERED 84
TABLE 27 MÖLNLYCKE AB: KEY DEVELOPMENTS 85
TABLE 28 B. BRAUN SE: PRODUCTS OFFERED 89
TABLE 29 SMITH+NEPHEW: PRODUCTS OFFERED 92
TABLE 30 CONVATEC GROUP PLC: PRODUCTS OFFERED 96
TABLE 31 CONVATEC GROUP PLC: KEY DEVELOPMENTS 97
TABLE 32 JOHNSON & JOHNSON INC.: PRODUCTS OFFERED 101
TABLE 33 MEDLINE INDUSTRIES LP: PRODUCTS OFFERED 103
TABLE 34 MEDLINE INDUSTRIES, LP: KEY DEVELOPMENTS 103
LIST OF FIGURES
FIGURE 1 FRANCE ADVANCED WOUND CARE MARKET: STRUCTURE
FIGURE 2 FRANCE ADVANCED WOUND CARE MARKET: MARKET GROWTH FACTOR ANALYSIS (2019-2035)
FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2035)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2024-2035)
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: FRANCE ADVANCED WOUND CARE MARKET
FIGURE 6 FRANCE ADVANCED WOUND CARE MARKET PRODUCT TYPE SEGMENT, 2024 & 2035 (USD MILLION)
FIGURE 7 FRANCE ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE, 2024 & 2035 (USD MILLION)
FIGURE 8 FRANCE ADVANCED WOUND CARE MARKET SHARE (%), BY PRODUCT TYPE, 2024
FIGURE 9 FRANCE ADVANCED WOUND CARE MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION)
FIGURE 10 FRANCE ADVANCED WOUND CARE MARKET, BY APPLICATION, 2024 & 2035 (USD MILLION)
FIGURE 11 FRANCE ADVANCED WOUND CARE MARKET SHARE (%), BY APPLICATION, 2024
FIGURE 12 FRANCE ADVANCED WOUND CARE MARKET, END USER SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION)
FIGURE 13 FRANCE ADVANCED WOUND CARE MARKET, BY END USER, 2024 & 2035 (USD MILLION)
FIGURE 14 FRANCE ADVANCED WOUND CARE MARKET SHARE (%), BY END USER, 2024
FIGURE 15 EUROPE ADVANCED WOUND CARE MARKET, END USER, 2019 & 2035 (USD MILLION)
FIGURE 16 FRANCE ADVANCED WOUND CARE MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024
FIGURE 17 COMPETITOR DASHBOARD: FRANCE ADVANCED WOUND CARE MARKET
FIGURE 18 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: SWOT ANALYSIS
FIGURE 20 3M: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 3M: SWOT ANALYSIS
FIGURE 22 COLOPLAST: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 COLOPLAST: SWOT ANALYSIS
FIGURE 24 PAUL HARTMANN AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 MÖLNLYCKE AB: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 B. BRAUN SE: SWOT ANALYSIS
FIGURE 28 SMITH+NEPHEW: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 SMITH+NEPHEW: SWOT ANALYSIS
FIGURE 30 CONVATEC GROUP PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 JOHNSON & JOHNSON INC.: FINANCIAL OVERVIEW SNAPSHOT
提及公司
Johnson & JohnsonInc.Smith + NephewIntegra Lifesciences Holdings Corporation3MConvaTech Group PlcPaul Hartmann AGColoplastMölnlycke ABB.Braun SEMedline IndustriesLP
同分類最新報告（醫療與生命科學）
查看醫療與生命科學全部報告 →
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們